Company Earnings Update 3 minutesRegister for Free AccessLoblaw (TSX: L) 4Q18 Results: Revenues Miss Expectations as Food Demand Proves “Moderate” and Pharmacy Sales Remain Soft Coresight Research February 22, 2019 Executive Summary Loblaw reported food retail same-store sales growth of 0.8% in 4Q18, versus 0.9% growth in the prior quarter. It reported drug retail same-store sales growth of 1.9% versus 2.5% growth the prior quarter. Total revenues of C$11.2 billion came in below the consensus estimate of C$11.27 billion recorded by StreetAccount. In FY19, the company expects to report positive same-store sales and a stable gross margin in its retail segment. Please Login to read the full report. Not a member? Register for a free user account. This document was generated for Other research you may be interested in: November 2023 China Retail Sales: Growth Continues To StrengthenAnalyst Corner—Explore Generative AI with John Harmon: Enormous Power and Potential, but Caution AdvisedJuly 2023 US Retail Traffic and In-Store Metrics: Signs of a Nonfood Recovery as YoY Declines EaseUS Apparel and Beauty Spending Tracker, September 2023: Clothing and Footwear Growth Softens Substantially, While Beauty Growth Remains Resilient
